Business Combinations (Tables)

12 Months Ended

Dec. 31, 2016

Summary of Contingent Acquisition Consideration Payable Recorded as Non-Current Liabilities in Accompanying Consolidated Balance Sheets

The following is a summary of the contingent acquisition consideration payable, recorded as a non-current liability in the accompanying consolidated balance sheets:

	Amount
	(in thousands)
Balance, December 31, 2015	$	4,278
Change in fair value of contingent acquisition    consideration payable		102
Balance, December 31, 2016	$	4,380

Cardiogen Sciences, Inc.

Summary of Contingent Acquisition Consideration Payable Recorded as Non-Current Liabilities in Accompanying Consolidated Balance Sheets

The following is the total consideration paid for the business combination:

	Amount
	(in thousands)
Fair value of shares issued	$	4,142
Fair value of contingent payments		4,147
Total consideration	$	8,289

Schedule of Fair Values of Assets Acquired and Liabilities Assumed at Acquisition Date

The following table summarizes the allocation of the consideration paid of $8.3 million to the fair values of the assets acquired and liabilities assumed at the acquisition date:

	Amount
	(in thousands)
In process research and development	$	8,000
Deferred tax liability		(3,260	)
Goodwill		3,631
Liabilities assumed (net of cash acquired)		(82	)
	$	8,289